Skip to Content

US Neurosurgical Holding Inc - Stock Quote USNU

Rating as of

Morningstar's US Neurosurgical Holding Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

US Neurosurgical Holding Inc's Company Profile

Business Description

US Neurosurgical Holding Inc operates as a holding company in United State. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

2400 Research Boulevard, Suite 325
Rockville, MD, 20850
T +1 301 208-8998
Sector Healthcare
Industry Medical Care Facilities
Most Recent Earnings Dec 31, 2021
Fiscal Year End Dec 31, 2022
Stock Type Distressed
Employees 3